November 2, 2010 – An estimated 1.1 million patients in the United States were treated in 2009 with radiation therapy, a 15 percent increase from 2007, according to a new study from IMV. The annual average increase is about seven percent.

Breast, prostate and lung cancer were the top three types of cancer treated with radiation, accounting for 24, 20 and 12 percent respectively.

“Digital imaging has become integrated into treatment planning, simulation and to guide tumor treatment real-time,” said Lorna Young, senior director, market research for IMV.

The 2010 Radiation Therapy Market Summary Report describes trends in the adoption of therapeutic techniques, equipment and radioactive agents. Highlights include:

• More than one-third of radiation therapy sites are planning to purchase external beam therapy units over the next three years.

• Of the treatment planning systems installed, more than half of the hardware or server technology has been upgraded, with the majority of the upgrades taking place in 2008 and 2009.

• 89 precent of radiation therapy sites have “record and verify” and/or oncology information systems installed. Two- thirds of the oncology information systems are interfaced with an EMR system, and 85 percent have digital images available on their system.

For more information: www.imvinfo.com


Related Content

News | Magnetic Resonance Imaging (MRI)

Jan. 27, 2026 — Hyperfine has announced results from the largest data set to date evaluating stroke detection with its ...

Time January 28, 2026
arrow
News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 20, 2026 — Hyperfine, the developer of the first FDA-cleared AI-powered portable MRI system for the brain — the ...

Time January 20, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Focused Ultrasound Therapy

Aug. 26, 2025 — In a quest for ever-more-effective treatments for pancreatic cancer, HonorHealth Research Institute is ...

Time August 29, 2025
arrow
Subscribe Now